Search
for

    Sort by

    Research 541–570 of 1000+

    1. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    2. Testosterone Supplementation for Aging-Associated Sarcopenia The Journals of Gerontology · 2003 · 92 citations
    3. Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide Journal of Medicinal Chemistry · 2008 · 88 citations
    4. Critical Developmental Periods for Effects on Male Rat Genitalia Induced by Finasteride, a 5α-Reductase Inhibitor Toxicology and Applied Pharmacology · 1993 · 86 citations
    5. Potential adverse effects of long-term testosterone therapy Baillière's clinical endocrinology and metabolism · 1998 · 72 citations
    6. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study Urology · 1999 · 65 citations
    7. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness Nature communications · 2017 · 64 citations
    8. Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy Integrative Cancer Therapies · 2010 · 61 citations
    9. Pre-receptor regulation of the androgen receptor Molecular and cellular endocrinology · 2007 · 56 citations
    10. Significance of the polyglutamine tract polymorphism in the androgen receptor Urology · 2001 · 54 citations
    11. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Proceedings of the National Academy of Sciences of the United States of America · 1993 · 53 citations
    12. BIOLOGICAL ACTIVITY OF ANTIANDROGENS 1970 · 51 citations
    13. Selective non-steroidal inhibitors of 5α-reductase type 1 2004 · 49 citations
    14. Tamoxifen for flutamide/finasteride-induced gynecomastia Urology · 1997 · 49 citations
    15. 5α-Reduced glucocorticoids: a story of natural selection Journal of Endocrinology · 2011 · 46 citations
    16. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    17. Cardiovascular Toxicities of Androgen Deprivation Therapy Current Treatment Options in Oncology · 2021 · 45 citations
    18. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride The Journal of Steroid Biochemistry and Molecular Biology · 2012 · 45 citations
    19. Anabolic effects of testosterone are preserved during inhibition of 5α-reductase 2007 · 42 citations
    20. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    21. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients Cell Transplantation · 2020 · 38 citations
    22. An Update on Plant Derived Anti-Androgens international journal of endocrinology and metabolism · 2012 · 38 citations
    23. Decreased fertility in male rats administered the 5α-reductase inhibitor, finasteride, is due to deficits in copulatory plug formation Reproductive Toxicology · 1991 · 37 citations
    24. Recent advances in thiasteroids chemistry Steroids · 2006 · 37 citations
    25. Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands 2009 · 36 citations
    26. Epitestosterone—an endogenous antiandrogen? 1989 · 35 citations
    27. Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin 1993 · 34 citations
    28. Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period The Journal of Urology · 2006 · 32 citations
    29. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic Frontiers in Endocrinology · 2021 · 29 citations
    30. Effects of lifelong testosterone exposure on health and disease using Mendelian randomization eLife · 2020 · 29 citations